You can purchase these opportunities directly through this portal, or contact the ASHG Exhibits team at to discuss package pricing and inclusions!


  • Booth: 306

Aceragen is a rare and orphan disease biopharmaceutical company. Our goal is to provide rare-disease patients with compelling new therapeutic options. Acid ceramidase deficiency presenting as Farber disease represents the first example of our approach in action. The disease can result in a great deal of suffering for patients and families. Aceragen is engaged in the clinical development of a recombinant version of the acid ceramidase enzyme (ACG-801).

Questions or Need Assistance?


Technical support: Support

For more tips, visit the FAQ.

Featured Products
View All

Want your product featured here? Click to upgrade your online exhibitor listing.